BigRNA

Drug discovery and biotech · by Deep Genomics

A proprietary, powerful BioFM trained on over a trillion signals derived from high-throughput sequencing datasets; predicts effects of genetic variants, fine-tunes for on/off-target effects of genetic medicines, and generates rich sequence embeddings for target biology discovery and molecular design.

What it does

A proprietary, powerful BioFM trained on over a trillion signals derived from high-throughput sequencing datasets; predicts effects of genetic variants, fine-tunes for on/off-target effects of genetic medicines, and generates rich sequence embeddings for target biology discovery and molecular design.

  • AI-driven drug discovery
  • Molecular design
  • Target biology discovery
  • RNA therapeutic development
Category
Drug discovery and biotech
Users
Pharmaceutical companies, Drug discovery teams
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Deep Genomics doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Deep Genomics. Ask for audit reports before you buy.

  • Administrative safeguards
  • Technical safeguards
  • Physical safeguards
  • Need-to-know access restriction
  • Record retention processes

Reviews

No reviews yet

Reviews come from people who use BigRNA at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim BigRNA